Osteoporosis Clinical Trial
Official title:
Radiological, Biological, Genetic and Micro-architectural Bone Determinants of Fractures in Men With Low Bone Mineral Density
Rational: Osteoporosis in men is responsible for one third of fragility fractures. However
the definition and especially the determinants of fracture in humans are less well known
than in women.
Primary Objective: To search radiologic, biochemical, genetic and micro-architecture bone
factors associated to fractures in men with low bone density.
Study design: case/control study (fracture vs. no fracture) with men selected according to
low bone density (Z-score<-2).
Eligibility criteria: Included subjects will be men whose age is ³ 40 and £ 70 years with a
Z-score< -2 at least at one of the 3 measured sites (wrist, lumbar spine, femoral neck).
Subjects with secondary osteoporosis will be excluded (corticosteroid treatment,
hypogonadism, …) Progress of the study: The recruitment will be over two years. The study
will include two periods, an inclusion visit and a period of 3 months to achieve
radiological and biological examinations. The subjects will be recruited in the 3
rheumatology departments (LARIBOISIERE, COCHIN). Subjects will be investigated at
LARIBOISIERE hospital to perform radiological examinations and biological sampling for
laboratory tests within 3 months of enrollment.
Evaluation criteria: Biochemistry: dosages of sexual steroids, bone remodeling markers and
homocysteine; Genetic: evaluation of polymorphism of candidates genes associated to
fragility fractures (collagen type I, homocysteine, LRP5); Radiology: evaluation of bone
micro-architecture with a scan of lumbar spine and hip and peripheral micro-scan (XTREME
sSCANCO) and bone densitometry at spine, femoral neck and wrist.
Duration of participation: there is no follow up Total duration of the study: 2 years and 3
months. Number of subjects: 100 patients with fracture and 100 controls without fracture
Statistical Analysis: Relationship between computed scan parameters at different sites, bone
micro-architectural parameters (peripheral scan), biological parameters, genetic markers and
the occurrence of fracture will be analyzed initially by univariate analysis (screening
process). This will help to reduce the number of variables analyzed at the second stage of
analysis (i.e. multivariate analysis).
Expected results: This study will help to evaluate radiological, biochemical and genetic
determinants of bone quality in men with decreased bone density. It will help to establish a
prospective study to evaluate predictive factors of fractures in men.
;
Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06287502 -
Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis
|
N/A | |
| Completed |
NCT03822078 -
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Denosumab (AMG 162) in Japanese Postmenopausal Women
|
Phase 1 | |
| Recruiting |
NCT05845021 -
Surgeon-Initiated Bone Health Referral Pathway in Patients Undergoing Lower Extremity Arthroplasty
|
N/A | |
| Completed |
NCT00092066 -
A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)
|
Phase 3 | |
| Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
| Completed |
NCT04736693 -
Replication of the HORIZON Pivotal Fracture Trial in Healthcare Claims Data
|
||
| Not yet recruiting |
NCT06431867 -
Primary Care Management of Osteoporosis in Older Women
|
||
| Completed |
NCT02922478 -
Role of Comorbidities in Chronic Heart Failure Study
|
||
| Recruiting |
NCT02616627 -
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
|
||
| Recruiting |
NCT02635022 -
Fragility Fracture Liaison Service and Anti-osteoporosis Medication Monitoring Service Study
|
||
| Active, not recruiting |
NCT02617303 -
Prevention of Falls and Its Consequences in Elderly People
|
N/A | |
| Completed |
NCT02566655 -
Clinical Trial of Intravenous Infusion of Fucosylated Bone Marrow Mesenchyme Cells in Patients With Osteoporosis
|
Phase 1 | |
| Completed |
NCT03420716 -
Symbiotic Yogurt, Calcium Absorption and Bone Health in Young Adult Women
|
N/A | |
| Completed |
NCT02559648 -
Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis
|
Phase 2 | |
| Not yet recruiting |
NCT02223572 -
Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture
|
N/A | |
| Unknown status |
NCT01913834 -
Nasally and sc Administered Teriparatide in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT02003716 -
DeFRA Questionnaire as an Anamnestic Form
|
N/A | |
| Not yet recruiting |
NCT01854086 -
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
|
N/A | |
| Completed |
NCT01694784 -
Understanding and Discouraging Overuse of Potentially Harmful Screening Tests
|
N/A | |
| Completed |
NCT01401556 -
C-STOP Fracture Trial
|
N/A |